DEBRA MATHIES: Open Payments
NPI 1861628299 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 11 payments from 7 companies in 2025. Trend: 2023 $114 · 2024 $156 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Medtronic, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13 |
Products named: Attruby, FARXIGA, VENASEAL, LEQVIO, MOUNJARO, Kerendia.
Industry payments across IN — which companies pay providers there.
